PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 105 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $231,000 | +148.4% | 372,734 | +77.9% | 0.00% | – |
| Q2 2016 | $93,000 | -64.9% | 209,535 | -17.2% | 0.00% | – |
| Q1 2016 | $265,000 | -61.2% | 253,122 | +9.1% | 0.00% | – |
| Q4 2015 | $683,000 | -3.9% | 232,018 | +3.0% | 0.00% | – |
| Q3 2015 | $711,000 | -45.1% | 225,253 | +2.9% | 0.00% | -100.0% |
| Q2 2015 | $1,296,000 | -33.2% | 218,936 | +20.6% | 0.00% | 0.0% |
| Q1 2015 | $1,939,000 | +31.5% | 181,474 | +15.5% | 0.00% | 0.0% |
| Q4 2014 | $1,474,000 | +39.2% | 157,073 | +13.9% | 0.00% | 0.0% |
| Q3 2014 | $1,059,000 | +12.3% | 137,901 | +31.2% | 0.00% | 0.0% |
| Q2 2014 | $943,000 | +233.2% | 105,146 | +98.1% | 0.00% | – |
| Q1 2014 | $283,000 | +106.6% | 53,077 | -2.6% | 0.00% | – |
| Q4 2013 | $137,000 | -4.9% | 54,485 | +3.4% | 0.00% | – |
| Q3 2013 | $144,000 | -4.0% | 52,718 | +26.6% | 0.00% | – |
| Q2 2013 | $150,000 | – | 41,638 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 1,134,578 | $10,654,000 | 7.22% |
| Consonance Capital Management LP | 3,427,789 | $32,187,000 | 4.15% |
| ACUTA CAPITAL PARTNERS, LLC | 604,075 | $5,672,000 | 3.83% |
| KOPP INVESTMENT ADVISORS LLC | 758,233 | $7,119,000 | 3.42% |
| Aisling Capital LLC | 2,010,000 | $18,874,000 | 2.86% |
| Broadfin Capital, LLC | 6,100,000 | $57,280,000 | 2.49% |
| THOMPSON DAVIS & CO., INC. | 154,760 | $1,453,000 | 1.68% |
| RUDMAN ERROL M | 300,000 | $2,817,000 | 1.14% |
| WALL STREET ASSOCIATES | 1,259,500 | $11,827,000 | 1.13% |
| Timpani Capital Management LLC | 291,377 | $2,736,000 | 1.08% |